Skip to main content
Clinical Trials/DRKS00029408
DRKS00029408
Active, not recruiting
未知

Kaia back pain for the treatment of non-specific low back pain in adult patients - a randomised controlled trial - SWA

Kaia Health Software GmbH0 sites87 target enrollmentSeptember 19, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
M54.85 Other back pain: thoracolumbar region M54.86 OtherBack pain : Lumbar region M54.87 Other back painLumbosacral region M54.88 Other back pain : Sacralacrococcygeal region M54.89 Other back pain : UnspecifiedSacral and sacrococcygeal region M54.99Back pain, unspecified : Thoracolumbar region M54.96Back pain, unspecified : Lumbar region M54.97 Back painunspecified : lumbosacral region M54.98 Back pain
Sponsor
Kaia Health Software GmbH
Enrollment
87
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2022
End Date
March 20, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age: 18 years and above
  • 2\. Low back pain (M54\.4, M54\.5, M54\.85\-89, M54\.95\-99\) lasting 4 weeks or longer or recurring back pain
  • 3\. ODI score above 20 % \= moderate disability at the screening and baseline visit
  • 4\. Able to speak, read and understand German
  • 5\. Willing and capable of providing informed consent to use Kaia Back Pain and participate in all assessments associated with the clinical study
  • 6\. In possession of a smartphone and willing and able to use it for study purposes

Exclusion Criteria

  • 1\. Diagnosis of specific underlying cause of back pain (red\-flags”) at baseline according to German treatment guidelines NVL (spinal fracture, spinal tumour, spinal infection, disc herniation with unambiguous symptoms, spinal stenosis, inflammatory back pain)
  • 2\. Prior or planned surgery for back pain
  • 3\. Chiropractic care, acupuncture, injections, or other non\-pharmacological treatment for back pain covered by statutory health care in the one month before screening
  • 4\. Self\-reported prior use of Kaia Back Pain or other digital applications to treat non\-specific back pain within 12 months prior to screening or plans to participate in any other investigational trials or protocols for back pain within 90 days
  • 5\. Inability to perform the exercises of Kaia Back Pain independently (e.g., inability to carry out exercises on the floor and to get back up)
  • 6\. Severe or unstable medical condition (e.g., unstable cardiac disease, active infection, stroke with residual neuromuscular effects, paralysis, gait imbalance, history of recent recurrent falls) as assessed by the investigator
  • 7\. Self\-reported concurrent conditions that could interfere with evaluation of back pain results, including fibromyalgia, rheumatoid arthritis, or inflammatory arthropathies affecting the knee or hip joints, or other conditions in the opinion of the investigator that may interfere with safety, conduct of the study, or evaluation
  • 8\. Known pregnancy at screening or plans to become pregnant during study

Outcomes

Primary Outcomes

Not specified

Similar Trials